US Stock MarketDetailed Quotes

EWTX Edgewise Therapeutics

Watchlist
  • 34.000
  • +0.430+1.28%
Close Nov 1 16:00 ET
  • 34.000
  • 0.0000.00%
Post 17:48 ET
3.19BMarket Cap-22222P/E (TTM)

Edgewise Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-28.99%-26.1M
-25.29%-28.6M
-74.69%-91.95M
-126.32%-26.83M
-84.39%-22.06M
-24.56%-20.23M
-81.56%-22.83M
-57.09%-52.64M
-25.86%-11.86M
-44.80%-11.96M
Net income from continuing operations
-46.71%-31.5M
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-57.99%-67.64M
-52.92%-19.42M
-35.13%-17.5M
Depreciation and amortization
15.84%534K
117.84%525K
221.93%1.73M
479.35%533K
201.21%497K
199.35%461K
89.76%241K
97.79%538K
17.95%92K
157.81%165K
Change In working capital
1,033.63%3.19M
-16.47%-2.32M
-138.18%-1.56M
-103.66%-201K
-52.95%974K
87.72%-342K
-189.81%-1.99M
-11.75%4.09M
313.80%5.49M
-32.68%2.07M
-Change in prepaid assets
158.93%977K
82.45%-63K
-144.70%-3.55M
-235.84%-379K
-508.95%-1.16M
14.49%-1.66M
-190.20%-359K
39.30%-1.45M
163.27%279K
-117.92%-190K
-Change in payables and accrued expense
81.38%2.39M
-19.68%-2.09M
-19.90%2.1M
-91.40%295K
88.68%2.23M
248.20%1.32M
-57.62%-1.75M
-62.72%2.62M
94.17%3.43M
-41.24%1.18M
-Change in other current liabilities
---171K
-241.38%-164K
-103.56%-104K
-106.58%-117K
-109.57%-103K
--0
383.33%116K
--2.92M
--1.78M
--1.08M
Cash from discontinued investing activities
Operating cash flow
-28.99%-26.1M
-25.29%-28.6M
-74.69%-91.95M
-126.32%-26.83M
-84.39%-22.06M
-24.56%-20.23M
-81.56%-22.83M
-57.09%-52.64M
-25.86%-11.86M
-44.80%-11.96M
Investing cash flow
Cash flow from continuing investing activities
985.65%37.37M
-647.10%-268.31M
245.78%102.89M
135.69%26.98M
188.97%23.42M
7,582.61%3.44M
56.25%49.04M
70.86%-70.58M
-635.34%-75.6M
16.73%-26.32M
Net PPE purchase and sale
70.88%-221K
93.20%-297K
-3.59%-5.75M
95.11%-161K
65.64%-457K
-37.00%-759K
-1,083.74%-4.37M
-730.24%-5.55M
-4,068.35%-3.29M
-194.90%-1.33M
Net investment purchase and sale
794.76%37.59M
-601.80%-268.01M
267.04%108.63M
137.54%27.14M
195.54%23.88M
726.97%4.2M
68.19%53.41M
73.08%-65.03M
-609.18%-72.3M
19.79%-24.99M
Cash from discontinued investing activities
Investing cash flow
985.65%37.37M
-647.10%-268.31M
245.78%102.89M
135.69%26.98M
188.97%23.42M
7,582.61%3.44M
56.25%49.04M
70.86%-70.58M
-635.34%-75.6M
16.73%-26.32M
Financing cash flow
Cash flow from continuing financing activities
429.00%1.95M
1,147,866.67%241.07M
-58.99%53.17M
17,587.46%52.99M
-100.16%-211K
106.15%369K
-71.23%21K
-30.45%129.64M
-203.41%-303K
350,413.51%129.69M
Net common stock issuance
--0
--239.15M
-59.26%52.62M
9,580.72%52.62M
--0
--0
--0
-30.61%129.17M
---555K
----
Proceeds from stock option exercised by employees
442.01%2M
9,071.43%1.93M
-1.66%713K
91.62%320K
-94.23%3K
-14.78%369K
-71.23%21K
101.39%725K
-43.00%167K
40.54%52K
Net other financing activities
----
----
34.26%-165K
-42.35%49K
----
----
----
-102.42%-251K
--85K
---82K
Cash from discontinued financing activities
Financing cash flow
429.00%1.95M
1,147,866.67%241.07M
-58.99%53.17M
17,587.46%52.99M
-100.16%-211K
106.15%369K
-71.23%21K
-30.45%129.64M
-203.41%-303K
350,413.51%129.69M
Net cash flow
Beginning cash position
-37.25%30.26M
291.47%86.1M
41.29%21.99M
-69.97%32.96M
73.42%31.81M
39.99%48.23M
41.29%21.99M
-85.16%15.57M
938.19%109.75M
-63.61%18.34M
Current changes in cash
180.50%13.22M
-312.80%-55.83M
897.42%64.1M
160.56%53.14M
-98.74%1.15M
-1.93%-16.42M
38.92%26.24M
107.19%6.43M
-1,856.84%-87.75M
329.47%91.41M
End cash Position
36.72%43.49M
-37.25%30.26M
291.47%86.1M
291.47%86.1M
-69.97%32.96M
73.42%31.81M
39.99%48.23M
41.29%21.99M
41.29%21.99M
938.19%109.75M
Free cash flow
-25.38%-26.32M
-6.26%-28.9M
-67.91%-97.69M
-78.18%-26.99M
-69.37%-22.52M
-24.97%-20.99M
-110.14%-27.19M
-70.24%-58.18M
-59.49%-15.15M
-52.57%-13.29M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -28.99%-26.1M-25.29%-28.6M-74.69%-91.95M-126.32%-26.83M-84.39%-22.06M-24.56%-20.23M-81.56%-22.83M-57.09%-52.64M-25.86%-11.86M-44.80%-11.96M
Net income from continuing operations -46.71%-31.5M-24.90%-28.53M-48.08%-100.16M-55.26%-30.14M-46.95%-25.71M-33.62%-21.47M-55.78%-22.84M-57.99%-67.64M-52.92%-19.42M-35.13%-17.5M
Depreciation and amortization 15.84%534K117.84%525K221.93%1.73M479.35%533K201.21%497K199.35%461K89.76%241K97.79%538K17.95%92K157.81%165K
Change In working capital 1,033.63%3.19M-16.47%-2.32M-138.18%-1.56M-103.66%-201K-52.95%974K87.72%-342K-189.81%-1.99M-11.75%4.09M313.80%5.49M-32.68%2.07M
-Change in prepaid assets 158.93%977K82.45%-63K-144.70%-3.55M-235.84%-379K-508.95%-1.16M14.49%-1.66M-190.20%-359K39.30%-1.45M163.27%279K-117.92%-190K
-Change in payables and accrued expense 81.38%2.39M-19.68%-2.09M-19.90%2.1M-91.40%295K88.68%2.23M248.20%1.32M-57.62%-1.75M-62.72%2.62M94.17%3.43M-41.24%1.18M
-Change in other current liabilities ---171K-241.38%-164K-103.56%-104K-106.58%-117K-109.57%-103K--0383.33%116K--2.92M--1.78M--1.08M
Cash from discontinued investing activities
Operating cash flow -28.99%-26.1M-25.29%-28.6M-74.69%-91.95M-126.32%-26.83M-84.39%-22.06M-24.56%-20.23M-81.56%-22.83M-57.09%-52.64M-25.86%-11.86M-44.80%-11.96M
Investing cash flow
Cash flow from continuing investing activities 985.65%37.37M-647.10%-268.31M245.78%102.89M135.69%26.98M188.97%23.42M7,582.61%3.44M56.25%49.04M70.86%-70.58M-635.34%-75.6M16.73%-26.32M
Net PPE purchase and sale 70.88%-221K93.20%-297K-3.59%-5.75M95.11%-161K65.64%-457K-37.00%-759K-1,083.74%-4.37M-730.24%-5.55M-4,068.35%-3.29M-194.90%-1.33M
Net investment purchase and sale 794.76%37.59M-601.80%-268.01M267.04%108.63M137.54%27.14M195.54%23.88M726.97%4.2M68.19%53.41M73.08%-65.03M-609.18%-72.3M19.79%-24.99M
Cash from discontinued investing activities
Investing cash flow 985.65%37.37M-647.10%-268.31M245.78%102.89M135.69%26.98M188.97%23.42M7,582.61%3.44M56.25%49.04M70.86%-70.58M-635.34%-75.6M16.73%-26.32M
Financing cash flow
Cash flow from continuing financing activities 429.00%1.95M1,147,866.67%241.07M-58.99%53.17M17,587.46%52.99M-100.16%-211K106.15%369K-71.23%21K-30.45%129.64M-203.41%-303K350,413.51%129.69M
Net common stock issuance --0--239.15M-59.26%52.62M9,580.72%52.62M--0--0--0-30.61%129.17M---555K----
Proceeds from stock option exercised by employees 442.01%2M9,071.43%1.93M-1.66%713K91.62%320K-94.23%3K-14.78%369K-71.23%21K101.39%725K-43.00%167K40.54%52K
Net other financing activities --------34.26%-165K-42.35%49K-------------102.42%-251K--85K---82K
Cash from discontinued financing activities
Financing cash flow 429.00%1.95M1,147,866.67%241.07M-58.99%53.17M17,587.46%52.99M-100.16%-211K106.15%369K-71.23%21K-30.45%129.64M-203.41%-303K350,413.51%129.69M
Net cash flow
Beginning cash position -37.25%30.26M291.47%86.1M41.29%21.99M-69.97%32.96M73.42%31.81M39.99%48.23M41.29%21.99M-85.16%15.57M938.19%109.75M-63.61%18.34M
Current changes in cash 180.50%13.22M-312.80%-55.83M897.42%64.1M160.56%53.14M-98.74%1.15M-1.93%-16.42M38.92%26.24M107.19%6.43M-1,856.84%-87.75M329.47%91.41M
End cash Position 36.72%43.49M-37.25%30.26M291.47%86.1M291.47%86.1M-69.97%32.96M73.42%31.81M39.99%48.23M41.29%21.99M41.29%21.99M938.19%109.75M
Free cash flow -25.38%-26.32M-6.26%-28.9M-67.91%-97.69M-78.18%-26.99M-69.37%-22.52M-24.97%-20.99M-110.14%-27.19M-70.24%-58.18M-59.49%-15.15M-52.57%-13.29M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data